Re: New Apabetalone Clinical Trial for Pulmonary Arterial Hypertension

...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Reply New Message

Prev Message Back To Forum Threaded View Next Message

BearDownAZ

Rank: President [?]

Points: 25003 [?]

Votes: 68 Score: 4.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: New Apabetalone Clinical Trial for Pulmonary Arterial Hypertension

in response to

New Apabetalone Clinical Trial for Pulmonary Arterial Hypertension

BearDownAZ

posted on May 02, 2019 10:48PM

The study investigating the pre-clinical therapeutic potential of apabetalone (RVX-208) in pulmonary arterial hypertension is now published.

Multicenter Preclinical Validation of BET Inhibition for the Treatment of Pulmonary Arterial Hypertension

Here's some more background about the Resverlogix PAH program from a prior post. And here's the news release on the trial funding.